A new study published on Thursday by Melbourne's Peter Doherty Institute for Infection and Immunity and RMIT University offers the first in-depth analysis of how messenger ribonucleic acid (mRNA) vaccines circulate and break down in the human bloodstream, according to Xinhua news agency.
A report shows that there are about 507 prophylactic or preventive vaccines currently in late-stage development, of which 88 are being developed using the mRNA technology
While our successful peptide-based vaccines targeting malaria only contain small protein fragments of a malaria protein, mRNA vaccines encode an entire malaria protein
Hyderabad: The Hyderabad-based Centre for Cellular and Molecular Biology (CCMB) on Friday has announced the development of country’s first potential mRNA vaccine candidate to fight SARS-CoV-2. The indigenously developed mRNA vaccine candidate is undergoing pre-clinical studies to evaluate its efficacy to protect against live virus infection, CCMB researchers on Friday said. The mRNA vaccine candidate […]
New Delhi: Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India’s first mRNA COVID vaccine to the regulator Drugs Controller General of India (DCGI) on Friday, said sources. The company has also developed an Omicron-specific vaccine which will be tested on humans for efficacy and immunogenicity. Earlier the DG, Indian Council […]
United Nations: Mourning the loss of lives lost due to the global Coronavirus pandemic, Prime Minister Narendra Modi on Saturday reiterated India’s commitment to start giving vaccines to needy persons in other countries, even as he gave a clarion call to manufacturers to “Come, Make Vaccine in India”. “For the last one-and-a-half years, the whole […]
The mRNA vaccines by Pfizer and Moderna contain genetic instructions for our cells to make the spike protein of the SARS-CoV-2, which the virus uses to infect and enter the human cells.
Hyderabad-based firm to run pivotal trial in India and seek emergency use authorisation, and target to reach one billion dose production capacity in 2022
Bahrain plans to inoculate everyone 18 years and older in the kingdom at 27 different medical facilities, hoping to be able to vaccinate 10,000 people a day.
